Gabriella Montes

ID: 1b83a3ed-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Teva and Alvotech Announce Launch of SIMLANDI (adalimumab-ryvk) Injection in the U.S.

Big Molecule Watch · June 5, 2024

Accord BioPharma, Inc. Announces FDA Approval of HERCESSI (trastuzumab-strf)

Big Molecule Watch · May 2, 2024

Fresenius Kabi and Formycon Reach Settlement Agreement for Ustekinumab Biosimilar Candidate in Europe and Canada

Big Molecule Watch · March 28, 2024

FDA Approves XOLAIR to Treat Children and Adults With One or More Food Allergies

Big Molecule Watch · February 21, 2024

Fresenius Kabi Launches TYENNE, The First Approved Tocilizumab Biosimilar In The European Union

Big Molecule Watch · November 7, 2023